accountPALO ALTO, Calif. & DEERFIELD, Ill.--(BUSINESS WIRE)--Affymax, Inc. (Nasdaq: AFFY) and Takeda Global Research & Development Center, Inc., U.S., today announced multiple posters on peginesatide (formerly known as Hematide���) have been accepted for...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Affymax and Takeda to Present Additional Peginesatide Phase 3 Data in Dialysis Patients at the National Kidney Foundation (NKF) 2011 Spring Clinical Meeting
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account